HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Meng-Yao Wu Selected Research

Cantharidin (Cantharides)

2/2021Author Correction: Cantharidin represses invasion of pancreatic cancer cells through accelerated degradation of MMP2 mRNA.
11/2018The combination of cantharidin and antiangiogenic therapeutics presents additive antitumor effects against pancreatic cancer.
10/2018The radiotherapy-sensitization effect of cantharidin: Mechanisms involving cell cycle regulation, enhanced DNA damage, and inhibited DNA damage repair.
11/2015Cantharidin and norcantharidin impair stemness of pancreatic cancer cells by repressing the β-catenin pathway and strengthen the cytotoxicity of gemcitabine and erlotinib.
7/2015PP2A inhibitors arrest G2/M transition through JNK/Sp1- dependent down-regulation of CDK1 and autophagy-dependent up-regulation of p21.
7/2015Cantharidin represses invasion of pancreatic cancer cells through accelerated degradation of MMP2 mRNA.
2/2015Tamoxifen enhances the anticancer effect of cantharidin and norcantharidin in pancreatic cancer cell lines through inhibition of the protein kinase C signaling pathway.
8/2014PP2A inhibitors suppress migration and growth of PANC-1 pancreatic cancer cells through inhibition on the Wnt/β-catenin pathway by phosphorylation and degradation of β-catenin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Meng-Yao Wu Research Topics

Disease

15Neoplasms (Cancer)
05/2022 - 01/2015
15Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 08/2014
6Breast Neoplasms (Breast Cancer)
02/2022 - 07/2014
3Inflammation (Inflammations)
08/2019 - 01/2016
3Neoplasm Metastasis (Metastasis)
11/2018 - 01/2015
2Colorectal Neoplasms (Colorectal Cancer)
05/2022 - 01/2018
2Incomplete Abortion
05/2022 - 01/2020
2Adenocarcinoma
12/2020 - 02/2017
2Stomach Neoplasms (Stomach Cancer)
12/2019 - 02/2019
1B-Cell Lymphoma (Lymphoma, B Cell)
04/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2021
1Urinary Bladder Neoplasms (Bladder Cancer)
11/2020
1Non-alcoholic Fatty Liver Disease
09/2019
1Colitis
08/2019
1Ulcerative Colitis
08/2019
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2017
1Necrosis
01/2017
1Carcinogenesis
07/2016
1Spinal Cord Injuries (Spinal Cord Injury)
05/2016
1Chronic Pancreatitis
01/2016
1Inborn Genetic Diseases (Disease, Hereditary)
02/2014
1Autoimmune Diseases (Autoimmune Disease)
02/2014
1Hematologic Diseases (Blood Diseases)
02/2014
1Bone Neoplasms (Bone Cancer)
05/2013
1Pain (Aches)
05/2013
1Neuralgia (Stump Neuralgia)
05/2013

Drug/Important Bio-Agent (IBA)

8Cantharidin (Cantharides)IBA
02/2021 - 08/2014
7CateninsIBA
08/2019 - 08/2014
4Conditioned Culture MediaIBA
01/2022 - 01/2015
4Messenger RNA (mRNA)IBA
02/2021 - 07/2015
4FH535IBA
07/2016 - 08/2014
3Biomarkers (Surrogate Marker)IBA
02/2022 - 02/2017
2Mifepristone (RU 486)FDA Link
05/2022 - 01/2020
2Misoprostol (Cytotec)FDA LinkGeneric
05/2022 - 01/2020
2Proteins (Proteins, Gene)FDA Link
02/2022 - 05/2013
2Biological ProductsIBA
06/2021 - 01/2019
2Cisplatin (Platino)FDA LinkGeneric
01/2017 - 07/2015
2norcantharidinIBA
11/2015 - 02/2015
1Long Noncoding RNAIBA
05/2022
1Proliferating Cell Nuclear Antigen (PCNA)IBA
04/2022
1Circulating Tumor DNAIBA
02/2022
1DNA (Deoxyribonucleic Acid)IBA
02/2022
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
02/2022
1Cyclin-Dependent Kinases (cdk Proteins)IBA
02/2022
1B7-H1 AntigenIBA
02/2022
1folfirinoxIBA
12/2020
1MicroRNAs (MicroRNA)IBA
12/2019
1Circular RNAIBA
12/2019
1FructoseIBA
09/2019
1peony root extractIBA
09/2019
1Interleukin-9 (Interleukin 9)IBA
08/2019
1Interleukin-4 (Interleukin 4)IBA
08/2019
1T Cell Transcription Factor 1IBA
08/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2019
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
02/2019
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2019
1RNA (Ribonucleic Acid)IBA
10/2018
1ginsenoside Rg3IBA
01/2018
1SolutionsIBA
02/2017
1Keratins (Keratin)IBA
02/2017
1Docetaxel (Taxotere)FDA Link
01/2017
1Fluorouracil (Carac)FDA LinkGeneric
01/2017
1MethylprednisoloneFDA LinkGeneric
05/2016
1dibutyldichlorotinIBA
01/2016
1LipopolysaccharidesIBA
01/2016
1Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
01/2016
1Epithelial Cell Adhesion MoleculeIBA
11/2015
1Erlotinib Hydrochloride (CP 358,774)FDA Link
11/2015
1GemcitabineFDA Link
11/2015
1Okadaic AcidIBA
07/2015
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
07/2015
1Hormones (Hormone)IBA
02/2015
1BromidesIBA
02/2015
1Protein Kinase CIBA
02/2015
1Estrogen ReceptorsIBA
02/2015
1TamoxifenFDA LinkGeneric
02/2015
1LuciferasesIBA
01/2015
1Epirubicin (Ellence)FDA LinkGeneric
07/2014
1ArtesunateIBA
07/2014
1CC ChemokinesIBA
05/2013

Therapy/Procedure

9Therapeutics
05/2022 - 01/2015
5Drug Therapy (Chemotherapy)
01/2018 - 07/2014
2Immunotherapy
12/2020 - 11/2020
2Radiotherapy
10/2018 - 01/2017
1Hematopoietic Stem Cell Transplantation
02/2014